Overview

A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers

Status:
Completed

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to compare the effect of CT327 to placebo against experimental induced superficial, deep and hyperalgesic pain. The secondary objectives are to elucidate the mechanisms of CT327 using experimental pain models.

Phase:

Phase 1

Details

Lead Sponsor:

Creabilis SA

Collaborators:

Aalborg Universitetshospital
Aalborg University Hospital

Treatments:

Mitogens